104 related articles for article (PubMed ID: 3392657)
1. Effect of diltiazem on infarct size, reperfusion flow and flow reserve: the effect of timing of treatment.
Grover GJ; Sleph PG; Parham CS
J Pharmacol Exp Ther; 1988 Jul; 246(1):263-9. PubMed ID: 3392657
[TBL] [Abstract][Full Text] [Related]
2. Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
Grover GJ; Schumacher WA
J Pharmacol Exp Ther; 1989 Feb; 248(2):484-91. PubMed ID: 2521899
[TBL] [Abstract][Full Text] [Related]
3. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
Rousseau G; Provost P; Tran D; Caillé G; Latour JG
J Pharmacol Exp Ther; 1994 Mar; 268(3):1252-60. PubMed ID: 8138938
[TBL] [Abstract][Full Text] [Related]
4. Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog.
Mizumura T; Nithipatikom K; Gross GJ
Cardiovasc Res; 1995 Apr; 29(4):482-9. PubMed ID: 7796441
[TBL] [Abstract][Full Text] [Related]
5. Effect of diltiazem on regional oxygenation of reperfused myocardium.
Acad BA; Kedem J; Weiss HR
J Pharmacol Exp Ther; 1989 Apr; 249(1):91-6. PubMed ID: 2709337
[TBL] [Abstract][Full Text] [Related]
6. Effect of thromboxane receptor blockade on oxygen supply/consumption variables during reperfusion in the anesthetized dog.
Grover GJ; Sleph PG; Weiss HR
J Pharmacol Exp Ther; 1990 Jun; 253(3):1097-102. PubMed ID: 2141635
[TBL] [Abstract][Full Text] [Related]
7. The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes.
Auchampach JA; Maruyama M; Cavero I; Gross GJ
J Pharmacol Exp Ther; 1991 Dec; 259(3):961-7. PubMed ID: 1762089
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary streptokinase: effects on reperfusion hemorrhage and regional myocardial blood flow in the anesthetized dog.
Higginson LA; Sheldrick KR; Temple SV; Beanlands DS
J Cardiovasc Pharmacol; 1987 May; 9(5):509-14. PubMed ID: 2439829
[TBL] [Abstract][Full Text] [Related]
9. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
Reimer KA; Jennings RB
Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
11. Effects of SQ 26,533 on reperfusion arrhythmias, ST-segment elevation and on infarct size in anesthetized dogs.
Saini RK; Fulmor IE; Parham CS; Antonaccio MJ
J Pharmacol Exp Ther; 1986 Apr; 237(1):1-8. PubMed ID: 3958960
[TBL] [Abstract][Full Text] [Related]
12. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
[TBL] [Abstract][Full Text] [Related]
13. Effect of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.
Bush LR; Romson JL; Ash JL; Lucchesi BR
J Cardiovasc Pharmacol; 1982; 4(2):285-96. PubMed ID: 6175813
[TBL] [Abstract][Full Text] [Related]
14. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
15. Absence of hemodynamic deterioration in the presence of amlodipine following experimental myocardial infarction.
Kloner RA; Hale SL; Alker KJ
J Cardiovasc Pharmacol; 1992; 20(5):837-45. PubMed ID: 1280749
[TBL] [Abstract][Full Text] [Related]
16. Myocardial perfusion distal to an acute or chronic coronary artery occlusion: effects of diltiazem and nifedipine.
Zyvoloski MG; Brooks HL; Gross GJ; Warltier DC
J Pharmacol Exp Ther; 1982 Aug; 222(2):494-500. PubMed ID: 7097568
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
18. Effects of immature recruitable collaterals on myocardial blood flow and infarct size after acute coronary occlusion.
Ramanathan KB; Wilson JL; Ingram LA; Mirvis DM
J Lab Clin Med; 1995 Jan; 125(1):66-71. PubMed ID: 7822947
[TBL] [Abstract][Full Text] [Related]
19. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM
Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of ischemia/reperfusion-induced myocardial infarction by the 2-alkynyladenosine derivative 2-octynyladenosine (YT-146).
Sasamori J; Aihara K; Yoneyama F; Sato I; Kogi K; Takeo S
J Cardiovasc Pharmacol; 2006 Apr; 47(4):614-20. PubMed ID: 16680077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
